期刊文献+

分级管理对乳腺癌化疗后胃肠道反应的预防效果分析 被引量:3

Preventive Effect of Graded Management on Gastrointestinal Reactions after Chemotherapy in Breast Cancer Patients
在线阅读 下载PDF
导出
摘要 目的:探讨分级管理对乳腺癌化疗后胃肠道反应的预防效果。方法:将2018年6月至2019年12月收治的90例乳腺癌化疗患者随机分为观察组和对照组各45例,对照组给予化疗所致恶心呕吐(CINV)常规防治方案,观察组给予CINV分级管理,比较2组患者化疗后恶心呕吐发生率和严重程度。结果:2组使用低度致吐药物患者的恶心、呕吐发生率比较差异无统计学意义(P>0.05),观察组使用中度致吐药物、高度致吐药物患者的恶心、呕吐发生率显著低于对照组(P<0.05);观察组患者恶心、呕吐症状以I级为主,观察组恶心呕吐症状严重程度明显轻于对照组(P<0.05)。结论:CINV分级管理可有效减少乳腺癌化疗所致恶心呕吐的发生,并减轻严重程度。 [Objective]To investigate the preventive effect of graded management on gastrointestinal reactions after chemotherapy in breast cancer.[Method]A total of 90 patients with breast cancer receiving chemotherapy from June 2018 to December 2019 were randomly divided into observation group(45 cases)and control group(45 cases).The control group was given the routine prevention and treatment of CINV,and the observation group was given the graded management of CINV.The incidence and severity of nausea and vomiting after chemotherapy were compared between the two groups.[Result]There was no statistically significant difference in the incidence of nausea and vomiting between the two groups(P>0.05).The incidence of nausea and vomiting in the observation group was significantly lower than that in the control group(P<0.05).The nausea and vomiting symptoms in the observation group were mainly grade I,the severity of nausea and vomiting in the observation group was significantly lower than that in the control group(P<0.05).[Conclusion]CINV graded management has a better effect on preventing gastrointestinal reactions caused by chemotherapy in breast cancer,which can effectively reduce the occurrence of nausea and vomiting and reduce the severity.
作者 沈英 郑叶平 沈丽莉 宋美芬 SHEN Ying;ZHENG Yeping;SHEN Lili;SONG Meifen(the Second Hospital of Jiaxing,Zhejiang 314000,China)
机构地区 嘉兴市第二医院
出处 《浙江医学教育》 2020年第6期35-37,51,共4页 Zhejiang Medical Education
基金 嘉兴市2019-2021年周期中医药重点学科建设计划资助(编号:2019XK-A07)。
关键词 乳腺癌 化疗 胃肠道反应 分级管理 breast cancer chemotherapy gastrointestinal reaction graded management
  • 相关文献

参考文献5

二级参考文献55

  • 1杨新杰,张树才.雷莫司琼预防肺癌顺铂化疗所致恶心呕吐效果的随机对照临床研究[J].中国肺癌杂志,2005,8(4):322-325. 被引量:13
  • 2陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:48
  • 3NCCN Clinical Practice Guidelines in Oncology: Antiemesis. version 1. 2014[EB/OL] .[2014-02-25]. http://www. nccn. orgl professionalsl physician_glsl pdfl antiemesis. pdf.
  • 4MASCC/ESMO. Antiemetic Guidelines 2013[EB/OL].[2014- 02-25]. http://www. mascc. orgl antiemetic-guidelines; 2013 MASccTM?.
  • 5Gralla RJ, Osoba D, Krismg, et al. Recommendations for the use of anti emetics : evidence-based, clinical practice guidelines[J] .J Clin Oncol, 1999, 17(9): 2971-2994.
  • 6徐建国.手术后恶心呕吐(PONV)防治快捷指南[EB/OL].2012[2014—02-25].http://www.csao].cn/bencandy.php?aid=6246.
  • 7Apfel CC, Heidrich FM,Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting[J] . BrJ Anaesth, 2012, 109(5): 742-753.
  • 8Warr DG, Grunberg SM, Gralla RJ, et al. The oral NK 1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting- Pooled data from 2 randomised, double-blind, placebo controlled trials[J]. EurJ Cancer, 2005, 41(9): 1278-1285.
  • 9Gralla R, Lichinitser M, Van Der Vegt S, et al. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron[J]. Ann Oncol, 2003, 14 ( 10) : 1570-1577.
  • 10Eisenberg P, Figueroa- VadilloJ, Zamora R, et al. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel SsH'L, receptor antagonist[J]. Cancer, 2003, 98( 11) : 2473-2482.

共引文献1658

同被引文献39

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部